J. Carl Barrett

Company: Precede Biosciences

Job title: Chief Scientific Officer

Seminars:

H&E-Based Biomarker Profiling In Precision Medicine: Opportunities & Challenges 2:40 pm

Exploring opportunities, challenges and practical takeaways of H&E base biomarker Profiling across a variety of different applications (research, drug development, the clinic)Read more

day: Day Three Track A

Comprehensive Epigenomic Profiling from Plasma to Inform Drug Development & Patient Selection in Oncology and Non-oncology 2:20 pm

Liquid biopsies are highly valuable assays for cancer diagnostic and treatment but going beyond genomics is key Epigenomics measures dynamic gene expression changes in cancers that can yield novel insights into cancer biology, pathways and targets Precede has developed an epigenomics profiling method of cancer from 1 ml plasma providing a genomic wide measurement of…Read more

day: Day Two Track B